[{"Assets_0_Q2_USD":"1210200000.0","CIK":"899923","CommonStockSharesIssued_0_Q2_shares":"80600000.0","CommonStockSharesOutstanding_0_Q2_shares":"80600000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.18","EarningsPerShareBasic_2_Q2_USD":"-0.43","EarningsPerShareDiluted_1_Q2_USD":"-0.18","EarningsPerShareDiluted_2_Q2_USD":"-0.43","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","MinorityInterest_0_Q2_USD":"0.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-96800000.0","NetIncomeLoss_1_Q2_USD":"-14100000.0","NetIncomeLoss_2_Q2_USD":"-34600000.0","OfficialName":"Myriad Genetics Inc. Common Stock","ProfitLoss_1_Q2_USD":"-14100000.0","ProfitLoss_2_Q2_USD":"-34600000.0","RevenuesConverted_1_Q2_USD":"179300000.0","RevenuesConverted_2_Q2_USD":"344200000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"947400000.0","StockholdersEquity_0_Q2_USD":"947400000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"80400000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"80300000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"80400000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"80300000.0","filed":"20220805","footnote":null,"form":"10-Q","fp":"Q2","fy":"2022.0","name":"MYRIAD GENETICS INC","period":"20220630","qtrs":"1","uom":"shares"}]